22 May 2013
Keywords: Agennix, talactoferrin, Fund raising, Cancer, Sepsis
Article | 01 April 2010
German drug developer Agennix is developing talactoferrin, a recombinant version of the human milk protein, lactoferrin, for the treatment of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 April 2010
© 2013 thepharmaletter.com